These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The BIN1 rs744373 Alzheimer's disease risk SNP is associated with faster Aβ-associated tau accumulation and cognitive decline. Franzmeier N; Ossenkoppele R; Brendel M; Rubinski A; Smith R; Kumar A; Mattsson-Carlgren N; Strandberg O; Duering M; Buerger K; Dichgans M; Hansson O; Ewers M; Alzheimers Dement; 2022 Jan; 18(1):103-115. PubMed ID: 34060233 [TBL] [Abstract][Full Text] [Related]
4. Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. Landau SM; Fero A; Baker SL; Koeppe R; Mintun M; Chen K; Reiman EM; Jagust WJ J Nucl Med; 2015 Apr; 56(4):567-74. PubMed ID: 25745095 [TBL] [Abstract][Full Text] [Related]
5. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease. Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW; Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191 [TBL] [Abstract][Full Text] [Related]
6. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Jack CR; Wiste HJ; Vemuri P; Weigand SD; Senjem ML; Zeng G; Bernstein MA; Gunter JL; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS; Brain; 2010 Nov; 133(11):3336-48. PubMed ID: 20935035 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide transcriptome analysis identifies novel dysregulated genes implicated in Alzheimer's pathology. Nho K; Nudelman K; Allen M; Hodges A; Kim S; Risacher SL; Apostolova LG; Lin K; Lunnon K; Wang X; Burgess JD; Ertekin-Taner N; Petersen RC; Wang L; Qi Z; He A; Neuhaus I; Patel V; Foroud T; Faber KM; Lovestone S; Simmons A; Weiner MW; Saykin AJ; Alzheimers Dement; 2020 Sep; 16(9):1213-1223. PubMed ID: 32755048 [TBL] [Abstract][Full Text] [Related]
8. Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease. Darst BF; Koscik RL; Racine AM; Oh JM; Krause RA; Carlsson CM; Zetterberg H; Blennow K; Christian BT; Bendlin BB; Okonkwo OC; Hogan KJ; Hermann BP; Sager MA; Asthana S; Johnson SC; Engelman CD J Alzheimers Dis; 2017; 55(2):473-484. PubMed ID: 27662287 [TBL] [Abstract][Full Text] [Related]
9. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals. Tosun D; Landau S; Aisen PS; Petersen RC; Mintun M; Jagust W; Weiner MW; Brain; 2017 May; 140(5):1499-1512. PubMed ID: 28334939 [TBL] [Abstract][Full Text] [Related]
10. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy. Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease. Roostaei T; Nazeri A; Felsky D; De Jager PL; Schneider JA; Pollock BG; Bennett DA; Voineskos AN; Mol Psychiatry; 2017 Feb; 22(2):287-295. PubMed ID: 27021820 [TBL] [Abstract][Full Text] [Related]